Case Report

Rhubarb-Centered Therapy for Intraductal Papillary Mucinous Neoplasm (IPMN): A Case Series and Integrative Medicine Exploration

Fan Le1, Yufang Xiao2, Huifang Brown3
  1. 1 Shanghai University of Traditional Chinese Medicine Affiliated Shuguang Hospital, China
  2. 2 Apprentice TCM Physician, Shanghai, China
  3. 3 American Institute of Acupuncture & Herbal Medicine, USA

Abstract

Intraductal papillary mucinous neoplasm (IPMN) is an increasingly recognized pancreatic cystic tumor with variable malignant potential. Surgical resection remains the standard treatment for high-risk cases, whereas low-risk patients are typically managed with surveillance. This study presents two clinical cases treated with a rhubarb-centered therapeutic strategy. Both patients demonstrated symptomatic improvement and stable imaging findings. These results suggest potential clinical value; however, further studies are required to validate efficacy and safety.

How to Cite

1.
Le F, Xiao Y, Brown H. Rhubarb-Centered Therapy for Intraductal Papillary Mucinous Neoplasm (IPMN): A Case Series and Integrative Medicine Exploration. Botanical Drugs [Internet]. 2026 Apr. 15 [cited 2026 Jul. 12];1:56-61. Available from: https://botanicaldrugs.org/index.php/pub/article/view/13
Endnote/Zotero/Mendeley (RIS) BibTeX

References

  1. Tanaka M, Fernández-del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17(5):738–753.
  2. Ohtsuka T, Fernández-del Castillo C, Furukawa T, et al. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2024;24(2):255–270.
  3. Khalid A, Brugge W. ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts. Am J Gastroenterol. 2007;102(10):2339–2349.
  4. Oyama H, Tada M, Takagi K, et al. Long-term risk of malignancy in branch-duct intraductal papillary mucinous neoplasms. Gastroenterology. 2020;158(1):226–237.e5.
  5. Ma T, Liang T. Surveillance of non-resected branch-duct intraductal papillary mucinous neoplasms: Is a simplified algorithm justified. Hepatobiliary Surg Nutr. 2025;14(1):136–139.
  6. Ardeshna DR, Cao T, Rodgers B, et al. Recent advances in the diagnostic evaluation of pancreatic cystic lesions. World J Gastroenterol. 2022;28(6):624–634.
  7. Del Chiaro M, Segersvärd R, Pozzi Mucelli R, et al. Comparison of current guidelines for management of pancreatic cystic neoplasms. Ann Surg. 2017;266(5):792–801.
  8. Fritz S, Klauss M, Bergmann F, et al. Small (Sendai-negative) branch-duct IPMNs: not harmless. Ann Surg. 2012;256(2):313–320.
  9. Dong X, Fu J, Yin X, et al. Emodin: a review of its pharmacology, toxicity and pharmacokinetics. Phytother Res. 2016;30(8):1207–1218.
  10. Srinivas G, Babykutty S, Sathiadevan PP, Srinivas P. Molecular mechanism of emodin action: transition from laxative ingredient to an antitumor agent. Med Res Rev. 2007;27(5):591–608.
  11. Huang Q, Lu G, Shen HM, Chung MC, Ong CN. Anticancer properties of anthraquinones from rhubarb. Nat Prod Rep. 2007;24(5):1007–1020.
  12. Li Y, Liu T, Peng B, et al. Emodin induces apoptosis of pancreatic cancer cells via mitochondrial pathway. Oncol Rep. 2020;43(2):523–532.
  13. Gilmore TD. Introduction to NF-κB: players, pathways, perspectives. Oncogene. 2006;25(51):6680–6684.
  14. Lawrence T. The nuclear factor NF-κB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651.
  15. Crippa S, Fernández-Del Castillo C, Salvia R, et al. Mucinous cystic neoplasms of the pancreas: is surgical resection still recommended? Ann Surg. 2012;256(3):510–518.
  16. Jang JY, Park T, Lee S, et al. Validation of international consensus guidelines for predicting malignancy in IPMN. Ann Surg. 2014;259(1):72–78.
  17. Wang ZQ, Chen Y, Wang Y, et al. Traditional Chinese medicine in cancer therapy: a review. J Ethnopharmacol. 2018;214:33–45.
  18. Shennong Bencao Jing (Divine Farmer's Materia Medica Classic). Anonymous, circa 200 CE.